Skip to content

Scailyte Quarterly Update December 2020

scailyte quarterly update december 2020

Scailyte Quarterly Update December 2020

Scailyte quarterly update, highlighting that the company is among the twelve finalists in a global competition for innovative University spin-offs organized by Nature Research and Merck. Scailyte has started a collaboration with Karolinska Institutet Sweden. Here is a quote from Petter Brodin, Associate Professor of Immunology – “I am happy to join forces with Scailyte AG to use single-cell analysis and advanced analytics towards better understanding human immune-mediated diseases.” Read more below:

About Scailyte

Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. 

Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.

For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.

ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.

Recent News

Machine learning meets multi-omics for precision medicine

Bringing industry and academia together to discuss the potential impact of single-cell analytics pow

Read more

Recent News

Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies

Register for Scailyte's webinar on "Understanding Resistant to CAR-T Immunotherapy to Develop Better

Read more

Recent News

VACANCY: Technical Lead / Product Owner for a clinical diagnostic software

Scailyte is a globally recognised spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

Recent News

VACANCY: Data Scientist in Biomarker Discovery

Scailyte is a globally recognized spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

Recent News

True precision medicine through single-cell science - Nature

ScaiVision identifies disease signatures predicting drug efficacy & drug mode of action. Precision m

Read more

Recent News

Scailyte AG Announces a partnership with Sirona DX

Scailyte AG announces a strategic partnership with Sirona DX for AI-driven end-point specific single

Read more

Recent News

WEBINAR: Supervised learning of disease-associated cell states and dynamics

Watch Scailyte's webinar on "Supervised learning of disease-associated cell states and dynamics" wit

Read more

Recent News

PODCAST: Discovering diseases with artificial intelligence

PODCAST: Discovering diseases with artificial intelligence. Listen to this episode of Binary Dreams

Read more

Recent News

01 /04

Machine learning meets multi-omics for precision medicine

Bringing industry and academia together to discuss the potential impact of single-cell analytics pow

Read more

Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies

Register for Scailyte's webinar on "Understanding Resistant to CAR-T Immunotherapy to Develop Better

Read more

Recent News

02 /04

VACANCY: Technical Lead / Product Owner for a clinical diagnostic software

Scailyte is a globally recognised spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

VACANCY: Data Scientist in Biomarker Discovery

Scailyte is a globally recognized spin-off from ETH Zürich and a pioneer in the field of single-cel

Read more

Recent News

03 /04

True precision medicine through single-cell science - Nature

ScaiVision identifies disease signatures predicting drug efficacy & drug mode of action. Precision m

Read more

Scailyte AG Announces a partnership with Sirona DX

Scailyte AG announces a strategic partnership with Sirona DX for AI-driven end-point specific single

Read more

Recent News

04 /04

WEBINAR: Supervised learning of disease-associated cell states and dynamics

Watch Scailyte's webinar on "Supervised learning of disease-associated cell states and dynamics" wit

Read more

PODCAST: Discovering diseases with artificial intelligence

PODCAST: Discovering diseases with artificial intelligence. Listen to this episode of Binary Dreams

Read more

Recent News